Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3Brain Neoplasms 2Oligodendroglioma 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Gliosarcoma 1Glioma 1Glioblastoma 1Castrate-resistant Metastatic Prostate Cancer 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Astrocytoma 1

Interventions

cabazitaxel 1XRP6258 1Prednisone 1Granulocyte Colony-Stimulating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Castrate-resistant Metastatic Prostate Cancer × cabazitaxel × Clear all
NCT01750866 2013-10-16

Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer

Case Comprehensive Cancer Center

Phase 2 Withdrawn
Genitourinary

Castrate-resistant Metastatic Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡